Keywords: ondansetron (PubMed Search)
Posted: 7/24/2014 by Fermin Barrueto, MD
Click here to contact Fermin Barrueto, MD
Ondansetron is a highly effective anti-emetic that, since it has gone generic, is also quite inexpensive. There have been some reports of QT prolongation and cardiac arrhythmias especially with the high-dose 32mg IV dose for chemotherapy patients.
Is still safe in our ED population? A large systematic review was done in this month's Ann Emerg Med July 2014,p19-31.
Take Home Points:
1) No reports of arrhythmia associated with single dose administration identified
2) 80% of 60 unique reports were IV
3) 83% had significant PMH or already on a QT prolonging drug
Conclusion: Ondansetron doesn't warrant routine EKG or electrolyt screening in oral administration.High dose IV and High Risk patients do require more vigilance with EKG and electrolyte screening.
Download the UMEM Pearls App!
Subscribe to daily UMEM Pearls (FREE!) via: